Debjit Chattopadhyay

Debjit Chattopadhyay joined Boenning & Scattergood, Inc., in August 2006 and
covers the medical technology sector. He covers biotechnology,
biopharmaceuticals and medical device companies. He is particularly interested
in rapidly developing research areas like RNA therapeutics, stem cells and
angiogenesis. From a diagnostic perspective, He follows companies developing
bioarray technologies. Before joining Boenning, he was a Research Fellow at
Memorial Sloan Kettering Cancer Center. At Sloan, he was actively involved in
the development of novel targeted therapeutics, vaccines and initiated research
in nanobiotechnology. He holds a PhD from the University of Connecticut.

Related Interviews:

November 17, 2008